Anteris Technologies Global Corp (AVR)

04:55 AM

Anteris Technologies advances toward PARADIGM trial after key regulatory and clinical milestones - Proactive financial news

04:55 AM

May 13, 2025

Anteris scales for pivotal PARADIGM Trial, plunging R&D investment into clinical activities - Proactive financial news

May 13, 2025

May 13, 2025

The morning catch up: ASX to extend gains as global optimism lifts markets - Proactive financial news

May 13, 2025

May 13, 2025

Anteris Technologies Advances Clinical Trial Efforts with DurAVR® THV - TipRanks

May 13, 2025

May 13, 2025

Anteris Technologies Reports Q1 2025 Results and Strategic Fund Allocation - TipRanks

May 13, 2025

May 13, 2025

Anteris Announces Results for the First Quarter of 2025 - The Manila Times

May 13, 2025

Apr 29, 2025

Anteris Technologies Files Amendment to Annual Report - TipRanks

Apr 29, 2025

Apr 28, 2025

Anteris Technologies Announces Cessation of Certain Securities - TipRanks

Apr 28, 2025

Apr 25, 2025

Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street - The Globe and Mail

Apr 25, 2025

Apr 24, 2025

ASX Runners of the Week: Redstone Resources, Anteris & Jindalee Lithium - businessnews.com.au

Apr 24, 2025

Apr 21, 2025

Cantor Fitzgerald maintains Anteris stock Overweight with $9 target By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Cantor Fitzgerald maintains Anteris stock Overweight with $9 target - Investing.com

Apr 21, 2025

Apr 07, 2025

Anteris Technologies Announces Cessation of Securities - TipRanks

Apr 07, 2025

Apr 07, 2025

Anteris Technologies Announces New Securities Quotation - TipRanks

Apr 07, 2025

Apr 03, 2025

NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World

Apr 03, 2025

Apr 02, 2025

Anteris Technologies Reports March 2025 CDI Adjustments - TipRanks

Apr 02, 2025

Mar 31, 2025

Anteris Technologies Marks Clinical Milestone with DurAVR® THV By Investing.com - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

Anteris reports over 100 patients treated with new heart valve By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Anteris Technologies Hits Milestone with DurAVR® Heart Valve Treatment - Zenopa

Mar 31, 2025

Mar 31, 2025

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Anteris reports over 100 patients treated with new heart valve - Investing.com

Mar 31, 2025

Mar 31, 2025

Anteris Technologies announces 100 patients treated with DurAVR THV - TipRanks

Mar 31, 2025

Mar 31, 2025

Anteris Technologies Achieves Key Milestone in Cardiac Care - TipRanks

Mar 31, 2025

Mar 31, 2025

Anteris Technologies Marks Clinical Milestone with DurAVR® THV - Investing.com

Mar 31, 2025

Mar 30, 2025

Anteris Technologies Achieves Milestone with DurAVR® Heart Valve - TipRanks

Mar 30, 2025

Mar 30, 2025

Anteris Technologies marks clinical milestone with more than 100 patients treated using flagship DurAVR® THV - Proactive financial news

Mar 30, 2025

Mar 25, 2025

ASX Health Stocks: Anteris plans for US IPO and listing on Nasdaq - MSN

Mar 25, 2025

Mar 24, 2025

Head to Head Survey: Anteris Technologies Global (NASDAQ:AVR) & United Health Products (OTCMKTS:UEEC) - Defense World

Mar 24, 2025

Mar 21, 2025

Anteris Technologies reports one-year patient outcomes for DurAVR THV - TipRanks

Mar 21, 2025

Mar 21, 2025

Anteris shares rise on positive valve trial results By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Anteris Reports One-Year Patient Outcomes for DurAVR® THV - The Manila Times

Mar 21, 2025

Mar 21, 2025

Anteris shares rise on positive valve trial results - Investing.com India

Mar 21, 2025

Mar 21, 2025

Anteris Technologies Unveils Positive DurAVR® Patient Outcomes - TipRanks

Mar 21, 2025

Mar 21, 2025

Anteris Technologies delivers strong one-year results for DurAVR® Transcatheter Heart Valve - Proactive financial news

Mar 21, 2025

Mar 18, 2025

Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 18, 2025

Mar 14, 2025

Anteris Technologies Global (NASDAQ:AVR) Stock Price Down 6.2% – What’s Next? - Defense World

Mar 14, 2025

Mar 13, 2025

Anteris Technologies: Advancing Toward FDA Approval with Positive Buy Rating - TipRanks

Mar 13, 2025

Mar 13, 2025

Anteris Technologies reports annual financial results By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 13, 2025

Anteris Technologies reports annual financial results - Investing.com India

Mar 13, 2025

Mar 13, 2025

Anteris Technologies 2024 financials strong following Nasdaq debut, with plans for heart valve pivotal trial this year - Proactive financial news

Mar 13, 2025

Mar 13, 2025

Anteris Technologies: A Trailblazing Year of Innovation and Expansion - Kondor EXP

Mar 13, 2025

Mar 12, 2025

The morning catch up: ASX to reverse losses despite war of words over tariffs - Proactive financial news

Mar 12, 2025